FDA Adverse Event Injury Summary report: N

COREVALVE TRANSCATHETER AORTIC VALVE

MDR report key: 7038059 · Received November 16, 2017

Report

Report Number
2025587-2017-02148
Event Type
Injury
Date Received
November 16, 2017
Date of Event
February 1, 2016
Report Date
November 16, 2017
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
NPT
PMA / PMN Number
P130021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GR
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

CITATION: KOSTOPOULOU A. MANAGEMENT OF CORONARY ARTERY DISEASE AND CONDUCTION ABNORMALITIES IN TRANSCATHETER AORTIC VALVE IMPLANTATION. CURR. TREAT OPTIONS CARDIOVASC MED. 2016 FEB;18(2):9 DOI: 10.1007/S11936-015-0432-8 EARLIEST DATE OF PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION, IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION VIA LITERATURE META-ANALYSIS REGARDING THE MANAGEMENT OF CORONARY ARTERY DISEASE AND CONDUCTION ABNORMALITIES IN TRANSCATHETER AORTIC VALVE IMPLANTATION. ALL DATA WERE COLLECTED FROM MULTIPLE STUDIES. THE OVERALL STUDY POPULATION INCLUDED 24,584 PATIENTS, OF WHOM, AT LEAST 4,801 WERE IMPLANTED WITH MEDTRONIC COREVALVE® (SERIAL NUMBERS AND SPECIFIC IMPLANT RATES NOT PROVIDED). AMONG ALL PATIENTS ADVERSE EVENTS INCLUDED: STROKE, CONDUCTION DISTURBANCES, PERMANENT PACEMAKER IMPLANTATION, CONVERSION TO OPEN HEART SURGERY, AND VASCULAR COMPLICATIONS. MULTIPLE MANUFACTURERS WERE NOTED IN THE LITERATURE; BASED ON THE AVAILABLE INFORMATION, A DIRECT CORRELATION COULD NOT BE MADE BETWEEN THE OBSERVED ADVERSE EVENTS AND MEDTRONIC PRODUCT. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
818662 COREVALVE TRANSCATHETER AORTIC VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT MEDTRONIC HEART VALVES DIVISION CRS

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention